{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:59:53Z","timestamp":1787677193306,"version":"build-2784847793"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:p>Initially overlooked in favor of T cell\u2013mediated rejection, the importance of the humoral alloimmune response has progressively emerged. As a result, antibody-mediated rejection is now widely recognized as the main cause of late allograft loss in most (if not all) types of solid-organ transplantation. Over the last 2 decades, vascularized composite allotransplantation (VCA) has appeared for replacing tissue defects in patients for whom no other satisfactory reconstructive options were available. Although it is now clear that VCA recipients can develop donor-specific antibodies, conclusions made in solid organ transplantation regarding antibody-mediated rejection may not systematically apply to VCA. Here, we propose to use the experience gained in organ transplantation to shed light on the path that shall be followed to evaluate and manage humoral alloreactivity in VCA recipients.<\/jats:p>","DOI":"10.1097\/tp.0000000000003164","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T18:43:54Z","timestamp":1581101034000},"page":"2003-2010","source":"Crossref","is-referenced-by-count":10,"title":["Humoral Alloreactivity in VCA Recipients: Should We Learn From Our Experience?"],"prefix":"10.1097","volume":"104","author":[{"given":"Antoine","family":"Sicard","sequence":"first","affiliation":[{"name":"Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot University Hospital, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Kanitakis","sequence":"additional","affiliation":[{"name":"Department of Pathology, Edouard Herriot University Hospital, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Dubois","sequence":"additional","affiliation":[{"name":"French National Blood Service (EFS), HLA Laboratory, D\u00e9cines-Charpieu, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Morelon","sequence":"additional","affiliation":[{"name":"Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot University Hospital, Lyon, France."},{"name":"Lyon-Est Medical Faculty, Claude Bernard University Lyon 1, Lyon, France."},{"name":"French National Institute of Health and Medical Research (INSERM) Unit 1111, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Thaunat","sequence":"additional","affiliation":[{"name":"Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot University Hospital, Lyon, France."},{"name":"Lyon-Est Medical Faculty, Claude Bernard University Lyon 1, Lyon, France."},{"name":"French National Institute of Health and Medical Research (INSERM) Unit 1111, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1600-6143.2011.03729.x","article-title":"Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome.","volume":"11","author":"Cantarovich","year":"2011","journal-title":"Am J Transplant"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ajt.13529","article-title":"Late failing heart allografts: pathology of cardiac allograft vasculopathy and association with antibody-mediated rejection.","volume":"16","author":"Loupy","year":"2016","journal-title":"Am J Transplant"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.12703\/P7-51","article-title":"Recent advances in renal transplantation: antibody-mediated rejection takes center stage.","volume":"7","author":"Pouliquen","year":"2015","journal-title":"F1000Prime Rep"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/ajt.13589","article-title":"Antibody-mediated rejection in lung transplantation: clinical outcomes and donor-specific antibody characteristics.","volume":"16","author":"Roux","year":"2016","journal-title":"Am J Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/S0140-6736(99)02062-0","article-title":"Human hand allograft: report on first 6 months.","volume":"353","author":"Dubernard","year":"1999","journal-title":"Lancet"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/MOT.0000000000000349","article-title":"Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation.","volume":"21","author":"Weissenbacher","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MOT.0000000000000242","article-title":"Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation?","volume":"20","author":"Thaunat","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2217\/imt.11.2","article-title":"Immune recognition and rejection of allogeneic skin grafts.","volume":"3","author":"Benichou","year":"2011","journal-title":"Immunotherapy"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation.","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM197001152820301","article-title":"Humoral antibodies in renal allotransplantation in man.","volume":"282","author":"Jeannet","year":"1970","journal-title":"N Engl J Med"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.4049\/jimmunol.152.10.5135","article-title":"Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity.","volume":"152","author":"Russell","year":"1994","journal-title":"J Immunol"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1172\/JCI93542","article-title":"Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection.","volume":"128","author":"Chen","year":"2018","journal-title":"J Clin Invest"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.trim.2011.11.003","article-title":"Humoral immunity in chronic allograft rejection: puzzle pieces come together.","volume":"26","author":"Thaunat","year":"2012","journal-title":"Transpl Immunol"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MOT.0000000000000040","article-title":"Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.","volume":"19","author":"Valenzuela","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff \u201805 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u201cCAN\u201d).","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/j.1600-6143.2009.02761.x","article-title":"Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining.","volume":"9","author":"Sis","year":"2009","journal-title":"Am J Transplant"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-6143.2009.02958.x","article-title":"Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice.","volume":"10","author":"Hirohashi","year":"2010","journal-title":"Am J Transplant"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ajt.15074","article-title":"Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome.","volume":"19","author":"Senev","year":"2019","journal-title":"Am J Transplant"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/TP.0b013e31817352b9","article-title":"H-Y antibody development associates with acute rejection in female patients with male kidney transplants.","volume":"86","author":"Tan","year":"2008","journal-title":"Transplantation"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MOT.0000000000000329","article-title":"Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection.","volume":"21","author":"Sicard","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/ki.2011.317","article-title":"A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection.","volume":"81","author":"Thaunat","year":"2012","journal-title":"Kidney Int"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1681\/ASN.2018080868","article-title":"Early acute microvascular kidney transplant rejection in the absence of anti-HLA antibodies is associated with preformed IgG antibodies against diverse glomerular endothelial cell antigens.","volume":"30","author":"Delville","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2013121277","article-title":"Endothelial cell antibodies associated with novel targets and increased rejection.","volume":"26","author":"Jackson","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.","volume":"352","author":"Dragun","year":"2005","journal-title":"N Engl J Med"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1681\/ASN.2015070781","article-title":"Effect of immunosuppressive drugs on humoral allosensitization after kidney transplant.","volume":"27","author":"Thaunat","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fimmu.2018.00275","article-title":"CD4+ T cell help is mandatory for naive and memory donor-specific antibody responses: impact of therapeutic immunosuppression.","volume":"9","author":"Chen","year":"2018","journal-title":"Front Immunol"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trre.2015.12.002","article-title":"Rabbit antithymocyte globulin and donor-specific antibodies in kidney transplantation: a review.","volume":"30","author":"Pascual","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/ajt.14109","article-title":"Reduction of extended-release tacrolimus dose in low-immunological-risk kidney transplant recipients increases risk of rejection and appearance of donor-specific antibodies: a randomized study.","volume":"17","author":"Gatault","year":"2017","journal-title":"Am J Transplant"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/ajt.14721","article-title":"De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.","volume":"18","author":"Bray","year":"2018","journal-title":"Am J Transplant"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/tri.12716","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-year observational results.","volume":"29","author":"Kr\u00e4mer","year":"2016","journal-title":"Transpl Int"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIg\/anti-CD 20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study.","volume":"89","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"6804678","DOI":"10.1155\/2017\/6804678","article-title":"Desensitization: overcoming the immunologic barriers to transplantation.","volume":"2017","author":"Sethi","year":"2017","journal-title":"J Immunol Res"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/TP.0000000000001650","article-title":"Long-term outcomes of kidney transplantation in patients with high levels of preformed DSA: the Necker high-risk transplant program.","volume":"101","author":"Amrouche","year":"2017","journal-title":"Transplantation"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/TP.0000000000001069","article-title":"B cells and antibodies in transplantation.","volume":"100","author":"Koenig","year":"2016","journal-title":"Transplantation"},{"key":"R40-20231002","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1600-6143.2009.02591.x","article-title":"Comparison of combination plasmapheresis\/IVIg\/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.","volume":"9","author":"Lefaucheur","year":"2009","journal-title":"Am J Transplant"},{"key":"R41-20231002","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/01.TP.0000442503.85766.91","article-title":"Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.","volume":"97","author":"Gupta","year":"2014","journal-title":"Transplantation"},{"key":"R42-20231002","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection.","volume":"29","author":"Eskandary","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R43-20231002","first-page":"51","article-title":"A systematic review and meta-analysis of rituximab in antibody-mediated renal allograft rejection.","volume":"2","author":"Hychko","year":"2011","journal-title":"Int J Organ Transplant Med"},{"key":"R44-20231002","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/TP.0000000000000958","article-title":"One-year results of the effects of rituximab on acute antibody-mediated rejection in renal transplantation: RITUX ERAH, a multicenter double-blind randomized placebo-controlled trial.","volume":"100","author":"Sautenet","year":"2016","journal-title":"Transplantation"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/tan.13387","article-title":"Efficacy and safety of BORTEZOMIB treatment for refractory acute antibody-mediated rejection-a pilot study.","volume":"92(Suppl 2)","author":"Slatinska","year":"2018","journal-title":"HLA"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/TP.0000000000000298","article-title":"Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.","volume":"98","author":"Orandi","year":"2014","journal-title":"Transplantation"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/ajt.13663","article-title":"C1 inhibitor in acute antibody-mediated rejection nonresponsive to conventional therapy in kidney transplant recipients: a pilot study.","volume":"16","author":"Viglietti","year":"2016","journal-title":"Am J Transplant"},{"key":"R48-20231002","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of tocilizumab (anti-interleukin-6 receptor monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant glomerulopathy in HLA-sensitized renal allograft recipients.","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transplant"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation.","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"key":"R50-20231002","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/lt.25177","article-title":"Prevalence, risk factors, and impact of donor-specific alloantibodies after adult liver transplantation.","volume":"24","author":"Vandevoorde","year":"2018","journal-title":"Liver Transpl"},{"key":"R51-20231002","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1600-6143.2011.03469.x","article-title":"Long-term follow-up in composite tissue allotransplantation: in-depth study of five (hand and face) recipients.","volume":"11","author":"Petruzzo","year":"2011","journal-title":"Am J Transplant"},{"key":"R52-20231002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.humimm.2019.03.002","article-title":"The role of B cell immunity in VCA graft rejection and acceptance.","volume":"80","author":"Kaufman","year":"2019","journal-title":"Hum Immunol"},{"key":"R53-20231002","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/tri.13096","article-title":"De novo donor-specific HLA antibodies after combined intestinal and vascularized composite allotransplantation: a retrospective study.","volume":"31","author":"Weissenbacher","year":"2018","journal-title":"Transpl Int"},{"key":"R54-20231002","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1600-6143.2011.03915.x","article-title":"Graft vasculopathy in clinical hand transplantation.","volume":"12","author":"Kaufman","year":"2012","journal-title":"Am J Transplant"},{"key":"R55-20231002","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.0105-2896.2009.00855.x","article-title":"Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of toll-like receptors in immunity.","volume":"233","author":"Lampropoulou","year":"2010","journal-title":"Immunol Rev"},{"key":"R56-20231002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acs.nanolett.5b03801","article-title":"B cells loaded with synthetic particulate antigens: a versatile platform to generate antigen-specific helper T cells for cell therapy.","volume":"16","author":"Sicard","year":"2016","journal-title":"Nano Lett"},{"key":"R57-20231002","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/ajt.12715","article-title":"The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplant.","volume":"14","author":"Chandraker","year":"2014","journal-title":"Am J Transplant"},{"key":"R58-20231002","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1111\/tri.12233","article-title":"Antibody-mediated rejection in hand transplantation.","volume":"27","author":"Weissenbacher","year":"2014","journal-title":"Transpl Int"},{"key":"R59-20231002","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/ajt.14218","article-title":"Face transplantation: partial graft loss of the first case 10 years later.","volume":"17","author":"Morelon","year":"2017","journal-title":"Am J Transplant"},{"key":"R60-20231002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/SLA.0b013e31826d90bb","article-title":"Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression.","volume":"257","author":"Schneeberger","year":"2013","journal-title":"Ann Surg"},{"key":"R61-20231002","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/TP.0b013e318198dbc7","article-title":"CD3+-mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab.","volume":"87","author":"Landin","year":"2009","journal-title":"Transplantation"},{"key":"R62-20231002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.tp.0000266899.93315.52","article-title":"Absence of C4d deposition in human composite tissue (hands and face) allograft biopsies: an immunoperoxidase study.","volume":"84","author":"Kanitakis","year":"2007","journal-title":"Transplantation"},{"key":"R63-20231002","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOT.0b013e3282f3df15","article-title":"Lymphoid neogenesis in chronic rejection.","volume":"13","author":"Thaunat","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"R64-20231002","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/TP.0000000000000882","article-title":"Capillary thrombosis in the skin: a pathologic hallmark of severe\/chronic rejection of human vascularized composite tissue allografts?","volume":"100","author":"Kanitakis","year":"2016","journal-title":"Transplantation"},{"key":"R65-20231002","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/TP.0000000000002070","article-title":"Desensitization and prevention of antibody-mediated rejection in vascularized composite allotransplantation by syngeneic hematopoietic stem cell transplantation.","volume":"102","author":"Wang","year":"2018","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:48:30Z","timestamp":1696225710000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003164","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,7]]}}}